Baha’a Jabali

Researcher

University of Arkansas for Medical Sciences

unknown

4 h-index 5 pubs 102 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Baha’a Jabali's research focuses on the discovery and development of small molecule inhibitors for various kinase targets. His work has led to the identification of novel compounds, including an orally active selective aurora kinase B inhibitor and pyrimido[4,5-b]indole derivatives with dual RET/TRKA inhibitory activity. Jabali has published five papers with 102 citations and an h-index of 4. He collaborates with researchers at the University of Arkansas for Medical Sciences, including Brendan Frett, Baku Acharya, Katie R. Ryan, and Noemi Garcia Garcia. His recent publications indicate an ongoing focus on medicinal chemistry and the development of therapeutics targeting cancer-related molecular mechanisms.

Metrics

  • h-index: 4
  • Publications: 5
  • Citations: 102

Selected Publications

  • Discovery of N-(3-fluorophenyl)-2-(4-((7-(1-methyl-1H-pyrazol-4-yl)quinazolin-4-yl)amino)phenyl)acetamide as the first orally active selective aurora kinase B inhibitor (2025) DOI
  • Discovery of 9H-pyrimido[4,5-b]indole derivatives as dual RET/TRKA inhibitors (2024) DOI
  • Kinase inhibitor macrocycles: a perspective on limiting conformational flexibility when targeting the kinome with small molecules (2023) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics